Page last updated: 2024-10-27

gliclazide and Pancreatic Neoplasms

gliclazide has been researched along with Pancreatic Neoplasms in 2 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research Excerpts

ExcerptRelevanceReference
"A 74-year-old woman with type 2 diabetes mellitus who had been treated with a sulfonylurea for 6 years began experiencing frequent episodes of hypoglycemia."1.34Insulinoma causing hypoglycemia in a patient with type 2 diabetes. ( Chang, WH; Chen, TL; Lei, WY; Wang, CY; Wang, TE; Yang, TL, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, HY1
Tiu, SC1
Chan, OK1
Lei, WY1
Wang, TE1
Chen, TL1
Chang, WH1
Yang, TL1
Wang, CY1

Other Studies

2 other studies available for gliclazide and Pancreatic Neoplasms

ArticleYear
Dual aetiologies for hyperinsulinaemic hypoglycaemia in one patient.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2007, Volume: 13, Issue:1

    Topics: Adult; Gliclazide; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Insulinoma; Male; Pan

2007
Insulinoma causing hypoglycemia in a patient with type 2 diabetes.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2007, Volume: 106, Issue:5

    Topics: Aged; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hyperinsulinism; Hypoglycemia; Hypoglyc

2007